Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-038966

Director acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sigal Charles Elliott · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-27 Grant or award : show line 1 in the form +8,000 39,806 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-27 Grant or award : show line 2 in the form Stock Option (Right to Buy) +16,000 16,000 D
Loading xslF345X06/wk-form4_1780010743.xml…